Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra

Journal of Neurochemistry

Volumn 90, Issue 1, 2004, Pages 245-254

  Salvatore, Michael F ^a   Zhang, Jin Lu ^a   Large, Delia M ^a   Wilson, Patsy E ^a   Gash, Clelland R ^a   Thomas, Theresa Currier ^a   Haycock, John W ^b   Bing, Guoying ^a   Stanford, John A ^a   Gash, Don M ^a   Gerhardt, Greg A ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b LOUISIANA STATE UNIV HLTH SCI C   (United States)

Author keywords

Aging; Dopamine; ERK; MEK; Parkinson's disease

Indexed keywords

DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; SERINE; TYROSINE 3 MONOOXYGENASE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DENDRITIC CELL; DOPAMINE RELEASE; IMMUNOBLOTTING; MALE; MICRODIALYSIS; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIMATE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SUBSTANTIA NIGRA;

AMPHETAMINE; ANIMALS; DOPAMINE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; MALE; MICRODIALYSIS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NEOSTRIATUM; NERVE GROWTH FACTORS; PHOSPHORYLATION; POTASSIUM; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RAS PROTEINS; RATS; RATS, INBRED F344; RECEPTOR PROTEIN-TYROSINE KINASES; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; PRIMATES;

EID: 3042770773     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02496.x     Document Type: Article

References (64)

1. Besset V., Scott R. P. and Ibanez C. F. (2000) Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase. J. Biol. Chem. 275, 39159-39166.
2. Bjorklund A. and Lindvall O. (1975) Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminal. Brain Res. 83, 531-537.
3. Bourque M. and Trudeau L. (2000) GDNF enhances the synaptic efficacy of dopaminergic neurons in culture. Eur. J. Neurosci. 12, 3172-3180.
4. Cass W. A. (1996) GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine. J. Neurosci. 16, 8132-8139.
5. Cass W. A. and Manning M. W. (1999) GDNF protection against 6-OHDA-induced reductions in potassium-evoked overflow of striatal dopamine. J. Neurosci. 19, 1416-1423.
6. Chauhan N. B., Siegel G. J. and Lee J. M. (2001) Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain. J. Chem. Neuroanat. 21, 277-288.
7. Coulpier M., Anders J. and Ibanez C. F. (2002) Coordinated activation of autophosphorylation sites in the RET receptor tyrosine kinase: importance of tyrosine 1062 for GDNF mediated neuronal differentiation and survival. J. Biol. Chem. 277, 1991-1999.
8. Crocker A. D. (1997) The regulation of motor control: an evaluation of the role of dopamine receptors in the substantia nigra. Rev. Neurosci. 8, 55-76.
9. Doxakis E., Wyatt S. and Davies A. M. (2000) Depolarisation causes reciprocal changes in GFRα-1 and GFRα-2 receptor expression and shifts responsiveness to GDNF and neurturin in developing neurons. Development 127, 1477-1487.
10. MAPK and JNK1, and their regulatory kinases MEK1 and MEK4, in adult rat central nervous system. J. Comp. Neurol. 398, 373-392.
11. Fox C. M. Gash D. M. Smoot M. K. and Cass W. A. (2001) Neuroprotective effects of GDNF against 6-OHDA in young and aged rats. Brain Res. 896, 56-63.
12. Gash D. M. Zhang Z. Ovadia A. et al. (1996) Functional recovery in parkinsonian monkeys treated with GDNE Nature 380, 252-255.
13. Gerhardt G. A., Cass W. A., Huettl P., Brock S., Zhang Z. and Gash D. M. (1999) GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys. Brain Res. 817, 163-171.
14. Gerhardt G. A., Cass W. A., Yi A., Zhang Z. and Gash D. M. (2002) Changes in somatodendritic but not terminal dopamine regulation in aged Rhesus monkeys. J. Neurochem. 80, 168-177.
15. Gill S. S., Patel N. K., Hotton G. R., O'Sullivan K., McCarter R., Bunnage M., Brooks D. J., Svendsen C. N. and Heywood P. (2003) Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 9, 589-595.
16. Grewal S. S., York R. D. and Stork P. J. S. (1999) Extracellular-signal- regulated kinase signaling in neurons. Curr. Opin. Neurobiol. 9, 544-552.
17. Grondin R., Zhang Z., Yi A., Cass W. A., Maswood N., Andersen A. H., Elsberry D. D., Klein M. C., Gerhardt G. A. and Gash D. M. (2002) Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain 125, 2191-2201.
18. Grondin R., Cass W. A., Zhang Z., Stanford J. A., Gash D. M. and Gerhardt G. A. (2003) Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged Rhesus monkeys. J. Neurosci. 23, 1974-1980.
19. Groves P. M., Wilson C. J., Young S. J. and Rebec G. V. (1975) Self-inhibition by dopaminergic neurons. Science 190, 522-525.
20. Guo Z., Du X. and Iacovitti L. (1998) Regulation of tyrosine hydroxylase gene expression during transdifferentiation of striatal neurons: changes in transcription factors binding the AP-1 site. J. Neurosci. 18, 8163-8174.
21. Haycock J. W. (1990) Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, and 40. J. Biol. Chem. 265, 11682-11691.
22. Haycock J. W. and Haycock D. A. (1991) Tyrosine Hydroxylase in Rat Brain Dopaminergic Nerve Terminals. J. Biol. Chem. 266, 5650-5657.
23. Haycock J. W., Ahn N. G., Cobb M. H. and Krebs E. G. (1992) ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ. Proc. Natl Acad. Sci. USA 89, 2365-2369.
24. Hebert M. A. and Gerhardt G. A. (1997) Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats. J. Pharmacol. Exp. Ther. 282, 760-768.
25. Hebert M. A., Van Horne C. G., Hoffer B. J. and Gerhardt G. A. (1996) Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis. J. Pharmacol. Exp. Ther. 279, 1181-1190.
26. Hoffer B. J., Hoffman A., Bowenkamp K., Huettl P., Hudson J., Martin D., Line L.-F. and Gerhardt G. A. (1994) Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182, 107-111.
27. Hoffman A. F., van Horne C. G., Eken S., Hoffer B. J. and Gerhardt G. (1997) In vivo microdialysis studies of somatodendritic dopamine release in the rat substantia nigra: effects of unilateral 6-OHDA lesions and GDNF. Exp. Neurol. 147, 130-141.
28. Hutter D., Yo Y., Chen W., Liu P., Holbrook N. J., Roth G. S. and Liu Y. (2000) Age-related decline in Ras ERK mitogen-activated protein kinase cascade is linked to a reduced association between Shc and EGF receptor. J. Gerontol. 55A, B125-B134.
29. Jaber M., Dumartin B., Sagne C., Haycock J. W., Roubert C., Giros B., Bloch B. and Caron M. G. (1999) Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Eur. J. Neurosci. 11, 3499-3511.
30. Jin G., Omori N., Li F., Sato K., Nagano I., Manabe Y., Shoji M. and Abe K. (2002) Activation of cell-survival signal Akt by GDNF in normal rat brain. Brain Res. 958, 429-433.
31. Lew J. Y., Garcia-Espana A., Lee K. Y., Carr K. D., Goldstein M., Haycock J. W. and Meller E. (1998) Increased site-specific phosphorylation of tyrosine hydroxylase accompanies stimulation of enzymatic activity induced by cessation of dopamine neuronal activity. Mol. Pharmacol. 55, 202-209.
32. Lindgren N., Goiny M., Herrera-Marschitz M., Haycock J. W., Hokfelt T. and Fisone G. (2002) Activation of extracellular signal-regulated kinases 1 and 2 by depolarization stimulates tyrosine hydroxylase phosphorylation and dopamine synthesis in rat brain. Eur. J. Neurosci. 15, 769-773.
33. Marco S., Saura J., Perez-Navarro E., Marti M. J., Tolosa E. and Alberch J. (2002) Regulation of c-Ret, GFRα1, and GFRα2 in the substantia nigra pars compacta in a rat animal model of Parkinson's disease. J. Neurobiol. 52, 343-351.
34. Miyazaki T. and Lacey M. G. (1998) Presynaptic inhibition by dopamine of a discrete component of GABA release in rat substantia nigra pars reticulata. J. Physiol. 513, 805-817.
35. Morice C., Nothias F., König S., Vernier P., Baccarini M., Vincent J. D. and Barnier J. V. (1999) Raf-1 and B-Raf proteins have similar regional distributions but differential subcellular localization in adult rat brain. Eur. J. Neurosci. 11, 1995-2006.
36. Murphy L. O., Smith S., Chen R.-H., Fingar D. C. and Blenis J. (2002) Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4, 556-564.
37. Nicole O., Ali C., Docagne F., Plawinski L., MacKenzie E. T., Vivien D. and Buisson A. (2001) Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway. J. Neurosci. 21, 3024-3033.
38. Nozaki C., Asai N., Murakami H., Iwashita T., Iwata Y., Horibe K., Klein R. D., Rosenthal A. and Takahashi M. (1998) Calcium-dependent Ret activation by GDNF and neurturin. Oncogene 16, 293-299.
39. Paden C., Wilson C. J. and Groves P. M. (1976) Amphetamine-induced release of dopamine from the substantia nigra in vitro. Life Sci. 19, 1499-1506.
40. Palfi S., Leventhal L., Chu Y., Ma S. Y., Emborg M., Bakay R., Deglon N., Hantraye P., Aebischer P. and Kordower J. H. (2002) Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. J. Neurosci. 22, 4942-4954.
41. Paratcha G., Ledda F., Baars L., Coulpier M., Besset V., Anders J., Scott R. and Ibanez C. F. (2001) Released GFRα1 potentiates downstream signaling, neuronal survival, and differential via a novel mechanism of recruitment of c-Ret to lipid rafts. Neuron 29, 171-184.
42. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.
43. Radnikow G. and Misgeld U. (1998) Dopamine D1 receptors facilitate GABAA synaptic currents in the rat substantia nigra pars reticulata. J. Neurosci. 18, 2009-2016.
44. Robertson G. S. and Robertson H. A. (1989) Evidence that 1-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms. J. Neurosci. 9, 3326-3331.
45. Rosenblad C., Georgievska B. and Kirik D. (2003) Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system. Eur. J. Neurosci. 17, 260-270.
46. Rosenblum K., Futter M., Jones M., Hulme E. C. and Bliss T. V. P. (2000) ERK I/II regulation by the muscarinic acetylcholine receptors in neurons. J. Neurosci. 20, 977-985.
47. Salvatore M. F., Garcia-Espana A., Goldstein M., Deutch A. Y. and Haycock J. W. (2000) Stoichiometry of tyrosine hydroxylase phosphorylation in the nigrostriatal and mesolimbic systems in vivo: effects of acute haloperidol and related compounds. J. Neurochem. 75, 225-232.
48. Salvatore M. F., Waymire J. C. and Haycock J. W. (2001) Depolarization-stimulated catecholamine biosynthesis: involvement of protein kinases and tyrosine hydroxylase phosphorylation sites in situ. J. Neurochem. 79, 349-360.
49. Sarabi A., Hoffer B. J., Olson L. and Morales M. (2001) GFR alpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area. J. Comp. Neurol. 441, 106-117.
50. th Annual Meeting, On-site Program, p. 41. October 19-23, 2003.
51. Smith Y. and Kievel J. Z. (2000) Anatomy of the dopamine system in the basal ganglia. TINS 23, 10, S28-10, S33.
52. Sun B. and Tank A. W. (2003) c-Fos is essential for the response of the tyrosine hydroxylase gene to depolarization or phorbol ester. J. Neurochem. 85, 1421-1430.
53. Sutherland C., Alterio J., Campbell D. G., LeBourdelles B., Mallet J., Haavik J. and Cohen P. (1993) Phosphorylation and activation of human tyrosine hydroxylase in vitro by mitogen-activated protein (MAP) kinase and MAP-kinase-activated kinases 1 and 2. Eur. J. Biochem. 217, 715-722.
54. Timmerman W. and Abercrombie E. D. (1996) Amphetamine-induced release of dendritic dopamine in substantia nigra pars reticulata: D1-mediated behavioral and electrophysiological effects. Synapse 23, 280-291.
55. Trupp M., Belluardo N., Funakoshi H. and Ibanez C. F. (1997) Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-α indicates multiple mechanisms of trophic actions in the adult rat CNS. J. Neurosci. 17, 3554-3567.
56. Trupp M., Scott R., Whittemore S. R. and Ibanez C. F. (1999) Ret-dependent and -independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells. J. Biol. Chem. 274, 20885-20894.
57. Walker D. G., Beach T. G., Xu R., Lile J., Beck K. D., McGeer E. G. and McGeer P. L. (1998) Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease. Brain Res. 792, 207-217.
58. 2+ channels and transmitter release. Neuron 32, 99-112.
59. Waymire J. C., Craviso G. L., Lichteig K., Johnston J. P., Baldwin C. and Zigmond R. E. (1991) Vasoactive intestinal peptide stimulates catecholamine biosynthesis in isolated adrenal chromaffin cells: Evidence for a cyclic AMP-dependent phosphorylation and activation of tyrosine hydroxylase. J. Neurochem. 57, 1313-1324.
60. Whitmarsh A. J. and Davis R. J. (1996) Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74, 589-607.
61. Wichmann T. and DeLong M. R. (1996) Functional and pathophysiological models of the basal ganglia. Curr. Opin. Neurobiol. 6, 751-758.
62. Wiklund P., Ekström P. A. R. and Edström A. (2002) Mitogen-activated protein kinase inhibition reveals differences in signaling pathways activated by neurotrophin-2 and other growth-stimulating conditions of adult mouse dorsal root ganglia neurons. J. Neurosci. Res. 67, 62-68.
63. Yang F., Feng L., Zheng F., Du Johnson S. W. J., Shen L., Wu C. and Lu N. (2001) GDNF acutely modulates excitability and A-type K+ channels in midbrain dopaminergic neurons. Nat. Neurosci. 4, 1071-1078.
64. You L., Ebner S. and Kruse F. E. (2001) Glial cell-derived neurotrophic factor (GDNF)-induced migration and signal transduction in corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 42, 2496-2504.